Cyclerion Therapeutics (CYCN) Market Capitalization (2019 - 2025)

Cyclerion Therapeutics has reported Market Capitalization for 7 years, with the latest figure at $4.7 million in Q4 2025.

• On a quarterly basis, Market Capitalization fell 42.76% year-over-year to $4.7 million in Q4 2025; TTM through Dec 2025 was $4.7 million, a 42.76% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, down 60.56% from the prior year.
• Market Capitalization was $4.7 million for Q4 2025 at Cyclerion Therapeutics, down from $8.5 million in the prior quarter.
• The five-year high for Market Capitalization was $139.3 million in Q2 2021, with the low at $4.7 million in Q4 2025.
• Average Market Capitalization over 5 years is $34.2 million, with a median of $9.4 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2022: Market Capitalization soared 129809.65% in 2021, then tumbled 82.87% in 2022.
• Over 5 years, Market Capitalization stood at $74.7 million in 2021, then plunged by 61.75% to $28.6 million in 2022, then tumbled by 70.98% to $8.3 million in 2023, then fell by 1.09% to $8.2 million in 2024, then sank by 42.76% to $4.7 million in 2025.
• The last three Market Capitalization figures came in at $4.7 million (Q4 2025), $8.5 million (Q3 2025), and $9.0 million (Q2 2025), per Business Quant data.